Atlas Trials

Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis

Clinical trial NCT01565408 · COMPLETED

Trial details

NCT number
NCT01565408
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
InflammationRheumatoid Arthritis
Start date
2012-03-01
Primary completion
2013-10-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.